The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CYCLONE 2: A phase 3 study of abemaciclib with abiraterone in patients with metastatic castration-resistant prostate cancer.
 
Matthew Raymond Smith
Consulting or Advisory Role - Ambrx; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst)
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Janssen; MSD; Roche; VCN Biosciences
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Mirati Therapeutics (Inst); Pfizer (Inst)
 
Tilman Todenhöfer
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/Merck; Bayer; Bristol-Myers Squibb/Sanofi; Janssen; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche; Sanofi/Aventis
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Basilea (Inst); Bayer (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer (Inst); RhoVac (Inst)
 
Jae-Lyun Lee
Stock and Other Ownership Interests - Amgen; Black Diamond Therapeutics; Innovent Biologics; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); GI Innovation (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Jose Angel Arranz Arija
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck; MSD Oncology; Novartis; Pfizer
Speakers' Bureau - Merck; Pfizer; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
 
Laura Mazilu
Consulting or Advisory Role - Accord Healthcare; Angelini Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sandoz; Sanofi; Swixx BioPharma
Speakers' Bureau - Accord Healthcare; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; JJ Innovative Medicine; Lilly; Merck; MSD; Novartis; Pfizer; Roche; Sandoz
 
Arun Azad
Honoraria - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Consulting or Advisory Role - Aculeus Therapeutics; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Ipsen; Janssen; Merck Serono; Merck Sharp & Dohme; Novartis; Noxopharm; Pfizer; Sanofi; Telix Pharmaceuticals; Tolmar
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Serono; Novartis
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma; Astellas Pharma (Inst); AstraZeneca; AstraZeneca (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hinova Pharmaceuticals (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono; Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Synthorx (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Hinova Pharmaceuticals; Janssen; Merck Serono; Pfizer; Sanofi; Tolmar
 
Teresa Alonso-Gordoa
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Eisai; Ipsen; Janssen-Cilag; Lilly; MSD Oncology; Pfizer
Research Funding - Ipsen; Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Ursula Brigid McGovern
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Aptitude Health; Bayer; Cancer Network; Clinical Care Options; Color Genomics; Great Debates and Updates; Journal of Clinical Pathways/Oncology Learning Network; Lantheus Medical Imaging; OncLive; Pfizer; Physicans' Education Resource; Springer; Targeted Oncology; Wiley
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Blackstone; Blue Earth Diagnostics; Janssen Oncology; Lilly; Pfizer; Sanofi/Aventis; Tolmar
Research Funding - Bayer; Janssen (Inst); Lilly (Inst); Pfizer (Inst)
 
Dingwei Ye
No Relationships to Disclose
 
Hiroyoshi Suzuki
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Bayer Yakuhin; Chugai Pharma; Daiichi Sankyo; Janssen Oncology; Janssen Research & Development; Lilly; MSD K.K; Nihon Medi-Physics; Pfizer; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer Yakuhin; Daiichi-Sankyo; Janssen; Kissei Pharmaceutical; Nippon Shinyaku; Novartis; Sanofi; Takeda
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Janssen (Inst); Nihonkayaku (Inst)
 
Rana R. McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Steven Ades
No Relationships to Disclose
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York; US UROLOGY PARTNERS; US UROLOGY PARTNERS
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Novartis; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Novartis; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Astra Zenerca; Bayer; Dendreon; Janssen Oncology; Merck; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; InVitae; InVitae; Janssen Oncology; Merck; Pfizer
 
Maarten Hulstijn
Employment - biotest (I); Lilly
Stock and Other Ownership Interests - Lilly
 
Andrew Lithio
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Karim Nacerddine
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer